ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GENF Genflow Biosciences Plc

1.45
0.00 (0.00%)
Last Updated: 08:00:19
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genflow Biosciences Plc LSE:GENF London Ordinary Share GB00BP2C3V08 ORD GBP0.0003
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.45 1.40 1.50 1.45 1.45 1.45 788,378 08:00:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 487k -1.34M -0.0046 -3.15 4.24M
Genflow Biosciences Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GENF. The last closing price for Genflow Biosciences was 1.45p. Over the last year, Genflow Biosciences shares have traded in a share price range of 1.375p to 5.50p.

Genflow Biosciences currently has 292,506,618 shares in issue. The market capitalisation of Genflow Biosciences is £4.24 million. Genflow Biosciences has a price to earnings ratio (PE ratio) of -3.15.

Genflow Biosciences Share Discussion Threads

Showing 1 to 14 of 1050 messages
Chat Pages: Latest  6  5  4  3  2  1
DateSubjectAuthorDiscuss
19/4/2022
15:03
Yeah I bought AAL @ 800p sold @ 900p thinking I was amazing, life goes on. Always gotta be a buyer for your shares

Big plans for GENF

aimofthegame6
19/4/2022
14:52
Yeah and I sold out at 30p LOL
buzzzzzzzz
15/4/2022
10:31
GENF cornerstone shareholder Ronald J Bauer (the beneficial owner of Theseus Capital) has in the past 24 hours been arrested in the UK following indictment on securities fraud and money laundering by the US SEC. He is alleged to have masterminded a US$100 million pump & dump scheme spanning multiple jurisdictions along with a number of other individuals.



The chairman here needs to answer some serious questions now as Bauer is also heavily involved at Yassine’s other haunt, NASDAQ-listed Pasithea Therapeutics.

Do your due diligence. This Bauer guy is trouble.

pandemonium
29/3/2022
11:01
Another good RNS today and some buying finally come into the stock. Not a lot available under 10p, once we break who knows where we go. BEN went from 10p to nearly £1 lol
aimofthegame6
16/3/2022
08:04
Great RNS today deals with any funding worries for the next two years!!!
buzzzzzzzz
01/2/2022
11:45
Heading in the right direction here.
Nice to see this hold up so well after the IPO.
Thanks

davealders
18/1/2022
15:46
Stepped aboard in the placing. If Here's hoping.
bscuit
18/1/2022
14:04
Tr1 holding just announced.

Adrian Beeston increased his share holding to 6% and now holds 17.55 million shares.
Very encouraging start to life here at Genflow.
I'm sure there will be more to come in the coming few months.
Thanks

davealders
17/1/2022
11:47
hxxps://audioboom.com/posts/8013627-traders-cafe-with-zak-mir-dr-eric-leire-ceo-genflow-biosciences



The Traders Cafe podcast with Zak Mir / Traders Cafe with Zak Mir: Dr Eric Leire, CEO Genflow Biosciences - audioboom.com
Zak Mir talks to Dr Eric Leire, CEO Genflow Biosciences, ahead of tomorrow's stock market debut of Europe's first longevity biotech company.
audioboom.com

buzzzzzzzz
17/1/2022
11:44
Hopefully this will do as well as Bens Creek.
buzzzzzzzz
17/1/2022
10:10
This one seems to be moving up extremely well already, can't see any sell prints
aimofthegame6
17/1/2022
09:01
Anyone participate in the IPO.

I did.

buzzzzzzzz
17/1/2022
08:57
Dave

How about putting chart in and also news?

buzzzzzzzz
17/1/2022
08:31
Welcome everyone to the future.
Very, very excited to be here.
Wishing the very best to Eric and the team.
Thanks

davealders
Chat Pages: Latest  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock